0001708138-20-000032.txt : 20200408 0001708138-20-000032.hdr.sgml : 20200408 20200408160249 ACCESSION NUMBER: 0001708138-20-000032 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200406 FILED AS OF DATE: 20200408 DATE AS OF CHANGE: 20200408 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Landry Robert E CENTRAL INDEX KEY: 0001585160 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 20782049 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2020-04-06 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001585160 Landry Robert E 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Finance CFO Common Stock 2020-04-06 4 M 0 3000 272.7 A 27373 D Common Stock 2020-04-06 4 F 0 2304 499.95 D 25069 D Common Stock 2020-04-07 4 S 0 694 497.5 D 24375 D Common Stock 2020-04-07 4 S 0 2 502.81 D 24373 D Common Stock 172 I By 401(k) Plan Non-Qualified Stock Option (right to buy) 272.7 2020-04-06 4 M 0 3000 0.0 D 2023-09-09 Common Stock 3000 42500 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Robert E. Landry 2020-04-07